Savaria Corp.(SIS-T)
TSX

Today's Change
Real-Time Last Update
Day Low30.05
Day High30.97
Open:30.83
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
SYNDTGAM
Small caps to watch: Propel Holdings, Kinaxis, Savaria and Thinkific set for active trading Thursday
{"Id":780514,"Name":"Don't expect big lift in stocks due to 'January Effect': Stephenson","Desc":"John Stephenson, President and CEO, Stephenson & Company discusses the so-called \"January effect\" and whether he thinks it will make a difference for markets in 2016.","ShortDesc":"John Stephenson, President and CEO, Stephenson & Company discusses the so-called \"January effect\" and whether he thinks it will make a...","Type":"segment","Episode":null,"AgvotCode":"E","AgvotDisclaimer":null,"QfrCode":"G","AiringOrder":null,"BroadcastDate":"2016-01-04","BroadcastTime":"08:10:15","BroadcastDateTime":"2016-01-04T08:10:15-05:00","LastModifiedDateTime":"2016-01-04T14:23:28Z","GameId":null,"Album":null,"Genres":[{"Id":154,"Name":"Commentary"},{"Id":40,"Name":"Investing"}],"Keywords":[{"Id":66203,"Name":"john stephenson","Count":139},{"Id":64202,"Name":"President","Count":273},{"Id":61326,"Name":"CEO","Count":342},{"Id":78657,"Name":"Stephenson & Company","Count":61},{"Id":70011,"Name":"january effect","Count":1},{"Id":61275,"Name":"markets","Count":1303},{"Id":61269,"Name":"stocks","Count":553},{"Id":75870,"Name":"tax-loss selling","Count":5},{"Id":63123,"Name":"small caps","Count":54},{"Id":63054,"Name":"prices","Count":20},{"Id":69699,"Name":"december","Count":2},{"Id":64558,"Name":"january","Count":0}],"Tags":[],"Images":[{"Type":"thumbnail","Url":"http://images.9c9media.com/image_asset/2016_1_4_a0629a30-951c-0133-524d-34b52f6f1279_jpg_940x529.jpg","Width":940,"Height":529}],"Authentication":{"Required":false,"Resources":null},"RatingWarnings":[],"People":[],"Funding":null,"MusicLabels":[],"BroadcastNetworks":[]}
GlobeNewswire
Savaria’s Second Quarter Delivers 8.4% Revenue Growth and Continued Margin Expansion
GlobeNewswire
Savaria Announces Date for Second Quarter 2026 Financial Results
GlobeNewswire
Savaria Declares Monthly Dividend
Motley Fool
An Ideal TFSA Stock Paying 1.8% Each Month
Motley Fool
How Investing $50,000 in These 3 Stocks Could Help You Reach $1 Million by Retirement
Motley Fool
5 Canadian Stocks to Buy and Hold for the Next 5 Years
GlobeNewswire
Savaria Establishes Elevator Manufacturing in Europe by Acquiring Vipal S.p.A.
Motley Fool
A Reliable Dividend Stock Worth Putting $20,000 Behind Right Now
Motley Fool
2 Canadian Stocks Primed to Surge in 2026
GlobeNewswire
Savaria Declares Monthly Dividend
Motley Fool
2 TSX Stocks Priced Under $100 With Serious Upside Potential
Motley Fool
2 Dividend Super Stars That Look Strong After Recent Pullbacks
Motley Fool
Here’s How I’d Invest $5,000 in Canadian Stocks Right Now
Motley Fool
An Ideal TFSA Stock Paying 2% Each Month
GlobeNewswire
Savaria Declares Monthly Dividend
Motley Fool
1 Top Dividend Stock to Buy and Hold for 10 Years
GlobeNewswire
Savaria Announces the Voting Results for its Annual General Meeting of Shareholders
The Globe and Mail
Small caps to watch: Earnings from Kinaxis, Savaria and Ag Growth with much more to come
The TMX Market Centre is shown in Toronto, Wednesday, Sept. 11, 2024.

Profile

Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are Accessibility and Patient Care. The Accessibility segment deals with manufacturing, designing, installing, and distributing elevators, platform lifts, and stairlifts for people with mobility challenges. The Patient Care segment includes the manufacturing and distribution of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market. The company derives maximum revenue from Accessibility segment.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.